From a poster presentation at AHA 2016:
Methods: The Healthcare Cost and Utilization Project’s Nationwide Inpatient Sample was utilized to identify a cohort of adults hospitalized with CA, identified through International Classification of Diseases-9 codes…
Results: In-hospital all-cause mortality significantly decreased over the 7-year study period (65.5%, 63.4%, 59.3%, 57.9%, and 57.0%, 56.0%, and 56.3% from 2006-2012). From 2006-2012, there was an overall rise in the use of coronary angiogram (12.8%, 13.0%, 14.7%, 15.0%, 14.3%, 14.7%, and 15.8%), percutaneous coronary intervention (PCI) (7.5%, 7.1%, 8.4%, 8.1%, 8.1%, 8.4%, and 8.9%), TH (0.2%, 0.3%, 0.6%, 1.2%, 1.9%, 2.8%, and 3.0%), and ECMO (0.1%, 0.1%, 0.1%, 0.2%, 0.2%, 0.3%, and 0.4%)…
Conclusions: During 2006-2012, a decline in mortality was accompanied by a steady rise in use of advanced therapies, including ECMO, TH, coronary angiogram, and coronary revascularization. Patients of younger age and with CAD were more likely to receive these advanced therapies.
No comments:
Post a Comment